Atacand Plus 16/12,5 mg; 32/12,5 mg; 32/25 mg Tablets
Try these: Panado Ivedal Zometa Zofaril

Atacand Plus 16/12,5 mg; 32/12,5 mg; 32/25 mg Tablets

S4
PDF Leaflet Revision Date: 12 January 2023
API: Candesartan Cilexetil And Hydrochlorothiazide | Company: Equity Pharmaceuticals

Clinical Summary

Quick overview from the medicine insert

Indication

Superficial corticosteroid responsive dermatoses.

Dosage (summary)

Apply 1 to 3 times daily; reduce to once daily or 2-3 times weekly after improvement.

Special Populations

  • Children under 2 years

Pregnancy & Breastfeeding

Not recommended during pregnancy or lactation.

Contraindications

  • Hypersensitivity to hydrocortisone butyrate
  • Viral, bacterial, mycotic infections
  • Ulcerous skin lesions
  • Corticosteroid-induced adverse reactions

Common side effects

  • Skin atrophy
  • Pruritis
  • Dermatitis
  • Erythema
  • Blurred vision

Counselling Points

  • Apply to clean, dry skin
  • Wash hands after application
  • Avoid use on broken skin

Serious warnings

  • Avoid contact with eyes
  • Risk of systemic adverse reactions
  • Potential for rebound flares

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Atacand Plus 16/12,5 mg; 32/12,5 mg; 32/25 mg Tablets
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW